Allahdadi KJ, Walker BR, Kanagy NL. ROK contribution to endothelin-mediated contraction in aorta and mesenteric arteries following intermittent hypoxia/hypercapnia in rats. Am J Physiol Heart Circ Physiol 293: H2911-H2918, 2007. First published August 24, 2007; doi:10.1152/ajpheart.00217.2007.-We reported previously that intermittent hypoxia with CO2 to maintain eucapnia (IH-C) elevates plasma endothelin-1 (ET-1) and arterial pressure. In small mesenteric arteries (sMA; inner diameter ϭ 150 m), IH-C augments ET-1 constrictor sensitivity but diminishes ET-1-induced increases in intracellular Ca 2ϩ concentration, suggesting IH-C exposure increases both ET-1 levels and ET-1-stimulated Ca 2ϩ sensitization. Because Rho-associated kinase (ROK) can mediate Ca 2ϩ sensitization, we hypothesized that augmented vasoconstrictor sensitivity to ET-1 in arteries from IH-C-exposed rats is dependent on ROK activation. In thoracic aortic rings, ET-1 contraction was not different between groups, but ROK inhibition (Y-27632, 3 and 10 M) attenuated ET-1 contraction more in IH-C than in sham arteries (50 Ϯ 11 and 78 Ϯ 7% vs. 41 Ϯ 12 and 48 Ϯ 9% inhibition, respectively). Therefore, ROK appears to contribute more to ET-1 contraction in IH-C than in sham aorta. In sMA, ROK inhibitors did not affect ET-1-mediated constriction in sham arteries and only modestly inhibited it in IH-C arteries. In ionomycin-permeabilized sMA with intracellular Ca 2ϩ concentration held at basal levels, Y-27632 did not affect ET-1-mediated constriction in either IH-C or sham sMA and ET-1 did not stimulate ROK translocation. In contrast, inhibition of myosin light-chain kinase (ML-9, 100 M) prevented ET-1-mediated constriction in sMA from both groups. Therefore, IH-C exposure increases ET-1 vasoconstrictor sensitivity in sMA but not in aorta. Furthermore, ET-1 constriction is myosin light-chain kinase dependent and mediated by Ca 2ϩ sensitization that is independent of ROK activation in sMA but not aorta. Thus ET-1-mediated signaling in aorta and sMA is altered by IH-C but is dependent on different second messenger systems in small vs. large arteries. sleep apnea; endothelin-1; vascular smooth muscle cells; Rho-associated kinase SLEEP APNEA IS A COMMON DISEASE affecting up to 20% of Americans (30) and is associated with many cardiovascular diseases including systemic and pulmonary hypertension, coronary artery disease, stroke, and cardiac arrhythmias (35). Although the exact mechanisms by which sleep apnea contributes to these disease states have yet to be defined, several studies show that sleep apnea is associated with increased levels of circulating endothelin-1 (ET-1) (18, 29, 43) . Furthermore, we have demonstrated that vasoconstrictor sensitivity to ET-1 is increased in a rat model of sleep apnea (19) and that ET-1 antagonism lowers blood pressure to control levels in rats treated with intermittent hypoxia with CO 2 to maintain eucapnia (IH-C). Therefore, elevated circulating ET-1 combined with increased constrictor sensitivity to the peptide may contribute to vascular pathologies in this condition.
rats treated with intermittent hypoxia with CO 2 to maintain eucapnia (IH-C). Therefore, elevated circulating ET-1 combined with increased constrictor sensitivity to the peptide may contribute to vascular pathologies in this condition.
Previously, we reported that IH-C exposure augments constrictor sensitivity to ET-1 in small mesenteric arteries (sMA) but does not increase the constrictor sensitivity to either phenylephrine (PE) or depolarizing levels of K ϩ (1) . Additionally, we observed that the augmented constriction to ET-1 in sMA from IH-C rats is not accompanied by greater increases in intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) (1) . This suggests that IH-C exposure alters the ET-1 signaling in sMA to increase receptor activation of Ca 2ϩ sensitization. Ca 2ϩ sensitization regulates vascular tone by increasing phosphorylation of 20-kDa myosin regulatory light chain (MLC 20 ) independent of changes in [Ca 2ϩ ] i (38) . The degree of MLC 20 phosphorylation is determined by both MLC kinase (MLCK) and MLC phosphatase (MLCP) activity. MLCK phosphorylates MLC 20 at Ser 19 , initiating cross-bridge cycling between actin filaments and myosin, which results in smooth muscle contraction. MLCP removes the phosphate and thus reduces actin and myosin binding and smooth muscle contraction. Constriction can be initiated by MLCK activation after increases in [Ca 2ϩ ] i (38) or by MLCP inhibition by protein kinase C (PKC), Rho-associated kinase (ROK) (39) , or other Ca 2ϩ -independent kinases (16) . Of these pathways, ROK has been strongly implicated in vascular smooth muscle contraction (20, 21, 34) .
RhoA and ROK can be activated by many agonists, including ET-1 (25, 31, 33) . RhoA, a small monomeric GTPase, becomes active after exchange of bound GDP for GTP and translocates to the plasma membrane where it stimulates ROK translocation and activation (20) . Active ROK, a serine/threonine kinase, inhibits MLCP through phosphorylation of the myosin-binding regulatory subunit (2) . Although ET-1 has been shown to signal through both PKC and ROK to inhibit MLCP, the present study is focused on the contribution of ROK-mediated Ca 2ϩ sensitization because this pathway has previously been shown to be upregulated in several forms of hypertension (4, 9, 23) .
To test the hypothesis that ROK contributes more to ET-1-mediated constriction in IH-C than in sham arteries, endothelium-disrupted arteries were exposed to increasing concentrations of ET-1 in the presence or absence of ROK inhibitors (Y-27632 and HA-1077). Because most studies that have examined ROK upregulation in hypertension have been conducted in conduit arteries (26, 41) and differences have been reported in the role of ROK in large vs. small arteries (3), we examined the effect of ROK inhibition in both fifth-order sMA and the larger thoracic aorta. Ionomycin-permeabilized sMA from IH-C and sham rats were used in some studies to more directly examine ET-1-stimulated Ca 2ϩ sensitization. Expression levels and ET-1-stimulated activation of ␣-ROK in IH-C and sham sMA were examined using Western blots. Finally, the contribution of MLCK to ET-1-induced vasoconstriction was investigated with the use of a selective inhibitor.
METHODS

Animals.
Male Sprague-Dawley rats (weighing 250 -300 g) were used for all studies. The IH-C protocol was as described previously (1, 19) . Briefly, animals were housed in Plexiglas boxes with free access to food and water and exposed to either IH-C (90-s stream of N2-CO2 to reach a nadir of 5% O2-5% CO2 followed by 90-s air flush) or sham treatment (air-air cycling), totaling 20 cycles/h for 7 h/day. A nadir of 5% O 2 was chosen to simulate the systemic hypoxemia observed in patients with severe sleep apnea, where minimum O2 saturations of ϳ70% are seen (35) . The CO2 level was chosen to maintain eucapnia (unpublished observations). Systolic blood pressure (SBP) and heart rate were recorded on days 0 and 14 to confirm our previous observation that this IH-C protocol increases blood pressure (1) . SBP was recorded before the start of the daily IH-C or air-air exposure using a standard tail-cuff apparatus (IITC). Body weight was recorded to determine the effect of the exposure protocol on weight gain. Approximately 16 h after the final IH-C exposure, animals were deeply anesthetized with pentobarbital sodium (150 mg/kg), and sMA and thoracic aorta were collected for constrictor studies.
All animal protocols were reviewed and approved by the Institutional Animal Care and Use Committee of the University of New Mexico Health Science Center and conform to National Institutes of Health guidelines for animal use.
Aortic ring contraction studies. Thoracic aortas were collected from IH-C and sham rats and placed in chilled physiological saline solution (PSS) (in mmol/l: 129.8 NaCl, 5.4 KCl, 0.83 MgSO 4, 19 NaHCO3, 1.8 CaCl2, 5.5 glucose, and 0.5 EGTA). Arteries were cleaned of connective tissue and surrounding fat and cut into 3-mm segments. Endothelial cells were removed by gently rubbing the lumen with fine-tipped forceps. Tissue rings were suspended in a bath containing warmed PSS maintained at 37°C and bubbled with 21% O2-6% CO2-73% N2 using metal hooks attached to Grass FT03 force transducers connected to amplifiers that fed into a data-acquisition program (Dataq, 3.01). Rings were stretched with 2,500 mg of passive tension and equilibrated for 60 min. After equilibration, viability was confirmed by contraction to PE (10 Ϫ6 mol/l), and endothelial integrity was assessed by relaxation to ACh (10 Ϫ6 mol/l) in rings contracted with PE. Segments relaxing Ͻ5% were used. Tissues were washed repeatedly over 60 min to remove PE and ACh and then exposed to increasing concentrations of ET-1 (10 Ϫ10 to 10 Ϫ7 mol/l) in the presence or absence of the ROK inhibitor Y-27632 (3 or 10 mol/l). Contractions are expressed as %PE (10 Ϫ6 M) contraction (8) . Pressurized mesenteric artery preparation. The intestinal arcade was removed and placed in a Silastic-coated Petri dish containing chilled PSS. Fifth-order artery segments were dissected from the mesenteric vascular arcade and placed in fresh PSS oxygenated with normoxic gas (21% O2-6% CO2-73% N2). Cleaned arterioles were transferred to a vessel chamber (Living Systems), cannulated with glass micropipettes, and secured with silk ligatures. The vessels were slowly pressurized to 60 mmHg with PSS using a servo-controlled peristaltic pump (Living Systems) and superfused with oxygenated 37°C PSS at 5 ml/min.
Endothelium disruption. The sMA endothelium was disabled in all experiments by passing 1 ml of air through the lumen. The integrity of the endothelium was assessed before and after disruption by exposing PE-constricted arterioles (10 Ϫ6 mol/l) to ACh (10 Ϫ6 mol/l). ACh-mediated vasodilation was eradicated in vessels with successfully disabled endothelium.
Vessel wall [Ca 2ϩ ]i detection. After arteries were denuded, pressurized sMAs (inner diameter of sham arteries ϭ 143.0 Ϯ 4.1 m; inner diameter of IH-C arteries ϭ 143.3 Ϯ 4.5 m) were loaded with the cell-permeable ratiometric Ca 2ϩ -sensitive fluorescent dye fura 2-AM (Molecular Probes). Fura 2-AM was dissolved in anhydrous DMSO (1 mmol/l). Directly before loading, fura 2-AM was mixed with a 20% solution of pluronic acid in DMSO and then added to PSS, yielding a final concentration of 2 mol/l fura 2-AM and 0.05% pluronic acid. Pressurized sMA were incubated 45 min in the dark at room temperature in air-bubbled fura 2-AM solution. After incubation, sMA were washed with 37°C PSS for 15 min to remove excess dye and to allow complete deesterification of the compound. Fura 2-loaded vessels were alternately excited at 340 and 380 nm at a frequency of 10 Hz with a dual-excitation light source (IonOptix Hyperswitch), and the respective 510-nm emissions were collected with a photomultiplier tube [ratio of 340-nm to 380-nm fluorescence (F 340/F380)]. Background-subtracted emission F340/F380 results were calculated with Ion Wizard software (IonOptix) and recorded continuously throughout the experiment with simultaneous measurement of inner diameter from bright-field images as described previously (27) .
Constrictor studies. After baseline internal diameter and F340/F380 were determined, constrictor studies to ET-1 (10 Ϫ10 to 10 Ϫ8 mol/l) were conducted in sham and IH-C sMA as reported previously (1) . The role of ROK in ET-1-mediated constriction was investigated with sMA pretreated with the ROK inhibitors Y-27632 (3 M; Calbiochem) or HA-1077 (fasudil, 10 M; Calbiochem) at concentrations shown to be effective at preventing ROK activation (12, 32) . After 10-min incubation with inhibitors, sMA were exposed to increasing concentrations of ET-1 (10 Ϫ10 to 10 Ϫ8 mol/l). Vessels were exposed to each concentration of agonist for 5 min in the continued presence of the inhibitors, and each artery was used for only one concentrationresponse curve. After ET-1 exposure, sMA were superfused with Ca 2ϩ -free PSS to cause complete relaxation and to demonstrate that the constriction was caused by reversible active tone. Constrictions are expressed as percent baseline diameter. Vessel wall Ca 2ϩ concentration is expressed as F340/F380 because the ratio is linearly related to true molar Ca 2ϩ concentration when the dissociation constant of fura 2 does not differ between treatment groups (14) .
Permeabilized studies. Arteries were prepared as described above. After fura 2-AM loading, vessels were superfused with Ca 2ϩ -free PSS. Once vessels were completely dilated, 3 M ionomycin (Calbiochem) was added to the Ca 2ϩ -free superfusate to permeabilize the vessel to Ca 2ϩ . After diameter and F340/F380 equilibrated, 300 nM Ca 2ϩ was added back to the superfusate to clamp [Ca 2ϩ ]i at approximate basal levels. Ca 2ϩ -clamped vessels were treated with vehicle, Y-27632 (3 M), or the myosin light-chain kinase inhibitor ML-9 (100 mol/l) for 10 min and then exposed to increasing ET-1.
To determine whether the entire vascular wall was penetrated by the ionomycin, some vessels were loaded intraluminally with fura 2-AM for 15 min and then washed with PSS to remove extracellular dye. The pressurized vessel was then permeabilized with ionomycin (3 M) in the superfusate and equilibrated in PSS with a calculated free Ca 2ϩ concentration of 300 nM as described above. The free Ca 2ϩ concentration for all studies was calculated with the use of the Kd of EGTA for Ca 2ϩ of 43.7 nM and the Kd of EGTA for Mg 2ϩ of 3.33 mM at 37°C and pH 7.4 (13) .
Protein analysis. To determine whether IH-C alters expression or activation of ROK in sMA, protein levels were evaluated as described previously (1) . Briefly, mesenteric artery cascades (2nd-to 5th-order inclusive) from sham and IH-C rats were cleaned of connective and adipose tissue, incubated with either vehicle or ET-1 (10 Ϫ8 ) for 30 min at 37°C, frozen in liquid nitrogen, and homogenized on ice in Tris ⅐ HCl buffer (pH 7.4) containing protease inhibitors. Homogenates were centrifuged at 1,500 g (4°C, 10 min) to remove insoluble material and then separated into cytosolic and particulate fractions by high-speed centrifugation (100,000 g at 4°C for 60 min). The cytosolic fraction was collected, and the particulate fraction was reconstituted in 100 l of Laemmli buffer. Proteins were separated in 4 -20% gradient polyacrylamide gels (Bio-Rad) and transferred to polyvinylidene difluoride membranes. Membranes were blocked in TBS with 0.05% Tween 20 detergent (TTBS) and 1% BSA (Sigma). After blocking was completed, membranes were incubated with a mouse monoclonal antibody specific for ␣-ROK II (1:500; BD Biodesign) in TTBS containing 1% BSA. Membranes were incubated with peroxidase-labeled goat anti-mouse IgG (1:5,000; Bio-Rad), washed in TTBS, and then analyzed with chemiluminescence labeling (Amersham). Membranes were exposed on Kodak BIOMAX film for 3-10 min. ␣-ROK band densities (SigmaGel; SPSS) were normalized to the total protein loaded per lane as determined by Coomassie blue staining of the membranes. Statistical analysis. Constriction and Ca 2ϩ concentration-response curves were analyzed by two-way repeated-measures ANOVA with Student-Newman-Keuls post hoc test for differences between groups and treatments. The EC 50 value or the concentration that produces 50% of the maximum response (Emax) was calculated for each concentration-response curve by nonlinear curve fitting using the Prism 3 GraphPad program, and group averages compared by oneway ANOVA with Student-Newman-Keuls post hoc test. Percent data were transformed to the square root of the arcsin before analysis to approximate a normal distribution (SigmaStat software; SPSS). P Ͻ 0.05 was considered statistically significant for all analyses. Table 1 shows a significant increase in SBP in rats exposed to IH-C for 14 days. Additionally, body weight (g) increased similarly in sham and IH-C rats over the 14 days of treatment.
RESULTS
Mesenteric arteries from IH-C rats constrict more to ET-1 (10 Ϫ10 to 10 Ϫ8 mol/l) than those from sham arteries (Fig. 1A ) without an increase in vessel wall Ca 2ϩ concentration (Fig.  1B) , consistent with our previous observations (1). The data in Table 2 further demonstrate that the maximum constriction (E max ) in IH-C sMA is greater than that in sham sMA, whereas the EC 50 is not different.
Effects of ROK inhibition on ET-1-mediated contraction in thoracic aorta.
In vehicle-treated arteries, ET-1-induced contraction was similar in sham and IH-C aortic rings. ROK inhibition with Y-27632 (3 and 10 mol/l) diminished ET-1-mediated contraction by 41 Ϯ 11 and 48 Ϯ 9% in sham aorta and by 50 Ϯ 11 and 75 Ϯ 7% in the IH-C aorta ( Fig. 2 and Table 2 ).
Effect of ROK inhibition on ET-1-mediated vasoconstriction in sMA.
In sham sMA, ROK inhibition with Y-27632 (3 mol/l) did not diminish ET-1-mediated constriction. Instead, constriction appeared to be slightly increased (Fig. 3A) . In IH-C sMA, the EC 50 for the ET-1-initiated constriction was slightly but not significantly reduced in the presence of the ROK inhibitor, but constriction at several concentrations was significantly less in the presence of the inhibitor (Fig. 3B and Table 2 ).
The ROK inhibitor HA-1077 (10 mol/l) also appeared to slightly augment ET-1-mediated constriction in sham sMA (Fig. 4A ) and diminished ET-1-mediated constriction in IH-C sMA, but again EC 50 and E max results were not significantly altered (Fig. 4B) .
In addition, Ca 2ϩ sensitivity was examined in permeabilized sMA with [Ca 2ϩ ] i held constant. Arteries were permeabilized with ionomycin (3 M), and superfusate [Ca 2ϩ ] i was held constant at 300 nM to keep F 340 /F 380 results similar to those in nonpermeabilized arteries at baseline. In permeabilized sMA, ROK inhibition did not affect ET-1-mediated constriction in either sham (Fig. 5A) or IH-C arteries (Fig. 5B) . Vessel wall Ca 2ϩ concentration ratios were unchanged throughout the protocol (Fig. 5, C and D) , indicating that arteries were successfully permeabilized in the presence of 3 M ionomycin.
Effects of MLCK inhibition on ET-1-mediated vasoconstriction. Clamping [Ca 2ϩ
] i at basal levels did not affect ET-1-mediated constriction in IH-C sMA compared with unclamped arteries. However, clamping [Ca 2ϩ ] i at basal levels reduced ET-1-mediated constriction in sham arteries compared with unclamped arteries (E max for sham arteries ϭ 82 Ϯ 5% and 72 Ϯ 4% and E max for IH-C arteries ϭ 100 Ϯ 7 and 99 Ϯ 6%, intact and permeabilized, respectively; Table 2 ), suggesting that maximal ET-1 constriction was more dependent on [Ca 2ϩ ] i and thus MLCK activation in sham sMA. To determine whether vasoconstriction by ET-1 was independent of Ca 2ϩ activation of MLCK in the IH-C sMA, permeabilized sMA were incubated with the MLCK inhibitor ML-9 (100 M), with superfusate [Ca 2ϩ ] i at 300 nM. ML-9 dramatically reduced ET-1-mediated constriction in both sham and IH-C sMA (Fig. 6, A and B Table 2 . There was an increase in E max in IH-C sMA but not aorta compared with sham controls. ROK inhibition did not affect E max in sMA; however, in aorta, ROK inhibition decreased it significantly, more in IH-C than in sham (52 Ϯ 9 and 25 Ϯ 7% in IH-C vs. sham). Permeabilization decreased E max in sham but not IH-C sMA.
ROK translocation by ET-1. Finally, to determine whether ET-1 stimulates the RhoA and ROK activation in sMA, ROK levels in the cytosol and particulate fractions of homogenized sMA from IH-C and sham rats were estimated by Western analysis. In addition, some sMA were stimulated with the maximum concentration of ET-1 (10 Ϫ8 mol/l) to evaluate agonist-induced translocation. Western analysis demonstrated that ROK is present in both the cytosol and particulate fractions of sham (Fig. 7A) and IH-C (Fig. 7B) sMA. However, ET-1 stimulation did not cause translocation of ROK to the particulate fraction, an observation consistent with the lack of effect of the ROK inhibitors in mesenteric artery constrictor studies (Figs. 3 and 4) .
DISCUSSION
ET-1 is an endogenous peptide shown to be an important regulator of vascular smooth muscle tone, especially in pathological conditions. Our previous studies suggest that augmented ET-1 vasoconstriction contributes to IH-C-induced hypertension (1, 19) , and the present study investigated a potential mechanism for this augmented response.
ET-1 initiates vasoconstriction through increases in both [Ca 2ϩ ] i and Ca 2ϩ sensitization (10, 33, 36) , but our previous studies suggested that only Ca 2ϩ sensitization is important in sMA from IH-C rats (1) . The purpose of this study was to examine ET-1 signaling in vascular smooth muscle from sham and IH-C rats to determine whether increased activation of the Ca 2ϩ -sensitizing small G protein RhoA/ROK contributes to the augmented constrictor response. The main findings of this study were 1) ET-1 contraction in both sham and IH-C thoracic aortic rings is ROK dependent; 2) in sMA, ROK activation is not a major mediator of ET-1-stimulated Ca 2ϩ sensitization in sMA, and ET-1 stimulation does not cause translocation of ROK; and 3) MLCK inhibition eliminates ET-1-mediated constriction in permeabilized IH-C and sham sMA. These data indicate that ET-1 mediates constriction through ROK in large but not in small arteries. In large arteries, the contribution of ROK appears to be increased in arteries from IH-C-treated rats but does not cause augmented vasoconstrictor sensitivity to ET-1. In contrast, ET-1 constrictor sensitivity is augmented in small arteries after IH-C treatment, but ROK appears to be a minor contributor to the response. Indeed, the effects of Y-27632 may be independent of ROK inhibition because HA-1077 (fasudil) did not have a significant effect and Y-27632 had no effect when vessel wall [Ca 2ϩ ] i was maintained constant. Interestingly, we observed that in sham sMA both ROK inhibitors slightly increased ET-1-mediated constriction (Figs. 3 and 4) . Although ROK in vascular smooth muscle cell has only been reported to regulate MLCP, these data suggest other signaling pathways may also be regulated by ROK, including vasodilatory pathways.
Overall, our data suggest that IH-C alters ET-1 signal transduction in both the larger aorta and smaller mesenteric arteries but has a much greater effect on vasoconstrictor sensitivity to ET-1 in small resistance arteries. This reinforces previous observations that ET-1 signaling is very different in large and small arteries (3) and is in agreement with our group's (19) previous finding that ET-1 receptor blockade lowers blood pressure in IH-C-treated rats.
In the sMA, ET-1-stimulated constriction required MLCK activation in both groups. Thus Ca 2ϩ activation of MLCK appears universally necessary for constriction. The apparent necessity of basal levels of Ca 2ϩ was further evidenced by the complete relaxation to Ca 2ϩ -free PSS and subsequent constriction to 300 nM Ca 2ϩ in both groups of permeabilized sMA. However, increased [Ca 2ϩ ] i appears to be required only in sham sMA to induce maximal ET-1 constriction, since holding vessel wall [Ca 2ϩ ] i constant significantly diminished constriction compared with that shown in the nonpermeabilized sham arteries but not in the IH-C arteries. Together, these results suggest Ca 2ϩ influx contributes more to constriction in sham than in IH-C sMA, consistent with our previous observations that ET-1-induced constriction in sMA from IH-C rats is independent of increases in vessel wall Ca 2ϩ concentration (1). Multiple studies have suggested augmented activation of ROK contributes to vascular changes in hypertension. Seko et al. (34) found that levels of active RhoA were increased in cultured aortic vascular smooth muscle cell from hypertensive compared with normotensive rats. The authors concluded that RhoA functions as a "molecular switch" in hypertension to augment constriction (34) . Weber and Webb (40) similarly demonstrated a greater effect of Y-27632 to relax serotonininduced constriction in superior mesenteric arteries from DOCA-salt hypertensive rats than in arteries from control rats. In addition, we observed that Y-27632 more effectively reverses ␣ 2 -adrenoceptor-mediated constriction in aorta from chronic nitric oxide synthase inhibition hypertensive rats than in control arteries (7) . Finally, the present study suggests that Y-27632 more completely prevents ET-1-dependent constriction in IH-C than in sham aortic rings. Therefore, ROK is implicated in certain vascular changes that occur in many different models of hypertension.
However, although ROK has been shown to be an important regulator of vascular tone in several different models of hypertension (15), ROK appears to play a small role in the augmented ET-1-mediated constriction of sMA from the hypertensive IH-C rats. One possibility is that alterations in ROK Fig. 7 . ROK is not translocated by ET-1 in mesenteric arteries. Western analysis of small mesenteric arteries from sham (A) and IH-C (B) rats (n ϭ 5) probed for ␣-ROK II in cytosolic (cyto) and particulate (part) fractions. Some arteries were stimulated with ET-1 (10 Ϫ8 mol/l) for 30 min before homogenization. Data are plotted as ratio of particulate to cytosolic fraction. Ratios were derived from arbitrary densitometry values, normalized to Coomassie blue staining to ensure equal loading.
signaling are greater in large than in small arteries, as suggested by the present data and several earlier studies. Budzyn et al. (5) reported that ROK inhibition reduces agonist-mediated constriction in the thoracic aorta and superior mesenteric artery but only minimally affects tone in small mesenteric artery branches. Mesenteric arteries used in the present study were smaller than those in the Budzyn study (150 vs. 300 m) and showed even less sensitivity to ROK inhibition. Therefore ET-1-induced ROK activation of Ca 2ϩ sensitization after hypertension might be limited to large vessels, whereas other mechanisms of Ca 2ϩ sensitization such as PKC play a more important role in small arteries (5) .
Alternatively, the contribution of ROK to Ca 2ϩ sensitization in small arteries may be agonist specific. ROK inhibition with Y-27632 significantly reduced PE-induced constriction in small femoral arteries (ϳ130 m) (22) and effectively reversed PE-mediated constriction but not ET-1-mediated constriction in a perfused mesenteric bed (6) . Similarly, myogenic tone is ROK mediated in small cerebral arteries (17) . Therefore, ROK may be activated by adrenergic agonists and myogenic tone but does not appear to be a major contributor to ET-1-induced constriction in the mesenteric resistance circulation.
The experiments with the MLCK inhibitor ML-9 were conducted to clarify whether ET-1 mediates contraction of the smooth muscle through Ca 2ϩ -dependent MLCK. Recent reports have suggested that MLC 20 can be phosphorylated independent of Ca 2ϩ and MLCK. Niiro and Ikebe (28) showed that activation of zipper-interacting protein kinase contracts rabbit mesenteric artery strips in the absence of Ca 2ϩ and phosphorylates both Ser 19 and Thr 18 of MLC 20 to activate cross-bridge cycling. Integrin-linked kinase similarly phosphorylates Ser 19 and Thr 18 to induce contraction of rat caudal artery strips (42) . The dramatic decrease in ET-1-mediated constriction of mesenteric arteries with MLCK inhibition (Fig. 6) does not preclude zipper-interacting protein kinase and integrin-linked kinase participation in ET-1-mediated constriction; however, combined with the requirement for basal [Ca 2ϩ ] i , it does suggest that Ca 2ϩ -activated MLCK is necessary for ET-1 constriction in these arteries.
Interestingly, oral Y-27632 lowers blood pressure to normal levels in nitro-L-arginine methyl ester-treated rats but does not affect blood pressure in control rats (34) , whereas fasudil increases forearm blood flow in hypertensive patients but not in normotensive controls (24) . Therefore, ROK inhibition appears to be an effective antihypertensive agent under certain conditions. However, if ROK contributes only minimally to ET-1 constriction of resistance arteries as seen here, it would not be predicted to be an effective target for treating ET-1-dependent hypertension.
In summary, the aim of the present study was to evaluate the contribution of RhoA/ROK to ET-1-mediated constriction in arteries from IH-C and sham rats. We demonstrated that ROK is not a major signaling component of ET-1-mediated vasoconstriction in IH-C mesenteric resistance arteries but contributes substantially to ET-1 contraction in the thoracic aorta. In addition, we demonstrated that Ca 2ϩ and MLCK are necessary for ET-1-mediated constriction of both IH-C and sham sMA. Thus it appears that augmented ET-1 constrictor sensitivity in small arteries after sleep apnea-induced hypertension is MLCK dependent yet ROK independent. However, in the aorta, ET-1-mediated contraction is mediated for the most part through ROK activation.
